Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts

Clinical and Experimental Metastasis

Volumn 14, Issue 3, 1996, Pages 197-208

  Himelstein, Bruce P ^a   Muschel, Ruth J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast carcinoma; MMP 9; Tumor host interactions

Indexed keywords

COLLAGENASE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL INTERACTION; ENZYME INDUCTION; ENZYME RELEASE; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN SYNTHESIS REGULATION; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, NORTHERN; BREAST NEOPLASMS; CARCINOMA; CELL COMMUNICATION; COCULTURE TECHNIQUES; COLLAGENASES; CULTURE MEDIA, SERUM-FREE; CULTURE TECHNIQUES; ENZYME INDUCTION; FEMALE; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 9; RATS; RNA, MESSENGER; TRYPSIN; TUMOR CELLS, CULTURED;

EID: 0030056669     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hamdy F, Fadlon E, Cottam D et al, 1994, Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer, 69, 177-82.
2. Davies B, Waxman J, Wasan H et al, 1993, Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res, 53, 5365-9.
3. Cottam D, Rennie I, Woods K, Parsons M, Bunning R and Rees R, 1992, Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Invest Opthal Vis Sci, 33, 1923-7.
4. Rao J, Steck P, Mohanam S, Stetler-Stevenson W, Liotta L and Sawaya R, 1993, Elevated levels of M, 92,000 type IV collagenase in human brain tumors. Cancer Res, 53, 2208-11.
5. Stahle-Backdahl M, Sudbeck B, Eisen A, Welgus H and Parks W, 1992, Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J Invest Dermatol, 99, 497-503.
6. Stahle-Backdahl M and Parks W, 1993, 92 kD gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol, 142, 995-1000.
7. Urbanski S, Edwards D, Maitland A, Leco K, Watson A and Kossakowska A, 1992, Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer, 66, 1188-92.
8. Kossakowska A, Urbanski S, Huchcroft S and Edwards D, 1992, Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNAs. Oncol Res, 4, 233-40.
9. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K, 1992, Localization of messenger RNA for M, 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res, 52, 1336-41.
10. Pyke C, Ralfkiaer E, Tryggvason K and Dano K, 1993, Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol, 142, 359-65.
11. Soini Y, Salo T, Oikarinen A and Autio-Harmainen H, 1993, Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas. Lab Invest, 69, 305-11.
12. Welgus H, Campbell E, Cury J et al, 1990, Neutral metalloproteinases produced by human mononuclear phagocytes. J Clin Invest, 86, 1496-502.
13. Campbell E, Cury J, Shapiro S, Goldberg G and Welgus H, 1991, Neutral proteinases of human mononuclear phagocytes: cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol, 146, 1286-93.
14. Oikarinen A, Kylmaniemi M, Autio-Harmainen H, Autio P and Salo T, 1993, Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol, 101, 205-10.
15. Canete-Soler R, Gui Y-H, Linask KK and Muschel RJ, 1995, Developmental expression of MMP-9 (Gelatinase B) mRNA in mouse embryos. Dev Dyn, 204, 30-40.
16. Fisher S, Cui T-Y, Zhang L et al, 1989, Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol, 109, 891-902.
17. Canete-Soler R, Litsky L, Lubensky I and Muschel RJ, 1995, Expression of MMP-9 (Gelatinase B) is associated with development of the nervous system. Dev Brain Res, 88, 37-52.
18. Basset P, Bellocq J, Wolf C et al, 1990, A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699-704.
19. Visscher DW, Hoyhtya M, Ottosen SK et al, 1994, Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer, 59, 339-44.
20. Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A and Autio HH, 1994, 72 kD and 92 kD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem, 42, 945-51.
21. Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW and Muschel RJ, 1995, Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metast, 1-6, 246-58.
22. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res, 53, 140-6.
23. Unemori E, Hibbs M and Amento E, 1991, Constitutive expression of a 92-kD gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest, 88, 1656-62.
24. Girard M, Matsubara M and Fini M, 1991, Transforming growth factor-β and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Opthalmol Vis Sci, 32, 2441-54.
25. Okada Y, Tsuchiya H, Shimizu H et al, 1990, Induction and stimulation of 92 kDa gelatinase Type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun, 171, 610-17.
26. 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem, 266, 11436-41.
27. Shima I, Sasaguri Y, Kusukawa J et al, 1993, Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal cell carcinoma in response to epidermal growth factor. Br J Cancer, 67, 721-7.
28. 1. J Biol Chem, 264, 1860-9.
29. r 95,000 type IV collagenase/ gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem, 268, 19143-51.
30. Sato H and Seiki M, 1993, Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405.
31. Sato H, Kita M and Seiki M, 1993, v-src activates the expression of 92-kDa type IV collagenase gene through the AP-I site and the GT box homologous to retinoblastoma control elements. J Biol Chem, 268, 23460-8.
32. Ballin M, Gomez D, Sinha C and Thorgeirsson U, 1988, Ras oncogene-mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun, 154, 832-8.
33. Ballin M, Mackay A, Hartzler JA, Pelina M and Thorgeirsson U, 1991, Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues. Clin Expl Metastasis, 9, 179-89.
34. Yamagata S, Yoshika I, Tanaka R and Shimizu S, 1988, Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun, 151, 158-62.
35. Welch DR, Fabra A and Nakajima M, 1990, Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA, 87, 7678-82.
36. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res, 50, 3872-7.
37. Bernhard E, Hagner B, Wong C, Lubenski I and Muschel R, 1995, The effect of E1A transfection on MMP-9 expression and metastatic potential. Int J Cancer, 60, 718-24.
38. Bernhard EJ, Gruber SB and Muschel RJ, 1994, Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA, 91, 4293-7.
39. Woessner J, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-54.
40. Birkedal-Hansen H, Moore W, Bodden M et al, 1993, Matrix metalloproteinases: a review. Crit Rev Oral Biol Med, 4, 197-250.
41. Okada Y, Gonoji Y, Naka K et al, 1992, Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem, 267, 21712-19.
42. Murphy G, Ward R, Hembry RM, Reynolds JJ, Kuhn K and Tryggvason K, 1989, Characterization of gelatinase from pig polymorphonuclear leucocytes. Biochem J, 258, 463-72.
43. Collier IE, Wilhelm SM, Eisen AZ et al, 1988, H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem, 263, 6579-87.
44. Hibbs M, Hoidal J and Kang A, 1987, Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest, 80, 1644-50.
45. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD and Goldberg GI, 1991, Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem, 266, 7870-5.
46. Ochieng J, Fridman R, Nangia MP et al, 1994, Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry, 33, 14109-14.
47. Ramos-DeSimone N, Moll U, Quigley J and French D, 1993, Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma, 12, 349-63.
48. Himelstein B, Canete-Soler R, Bernhard E and Muschel R, 1994, Induction of fibroblast 92 kDa gelatinase type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci, 107, 477-86.
49. Monsky WL, Kelly T, Lin CY et al, 1993, Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res, 53, 3159-64.
50. Noel AC, Polette M, Lewalle JM et al, 1994. Coordinate enhancement of gelatinase A mRNA and activity levels in human Fibroblasts in response to breast-adeno-carcinoma cells. Int J Cancer, 56, 331-6.
51. Chomczynski P and Sacchi N, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem, 162, 156-9.
52. Muschel RJ, Zhang HB, Iliakis G and McKenna WG, 1991, Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res, 51, 5113-17.
53. Goustin A, Leof E, Shipley G and Moses H, 1986, Growth factors and cancer. Cancer Res, 46, 1015-19.
54. r 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res, 55, 963-7.
55. Bowden G, Knox J, Powell W et al, 1995, The role of matrilysin in human prostate tumor cell invasion. J Cell Biochem, Suppl. 19B, 3.